| abstract |
Disclosed is an oral solution comprising 20-50 mg/mL telbivudine or a pharmaceutically acceptable salt thereof, sodium saccharin, passion fruit flavor, benzoic acid, and citrate buffer, wherein said oral solution is buffered to a pH range of about 4 to about 5. |